{"id":58564,"date":"2016-04-05T21:03:02","date_gmt":"2016-04-05T21:03:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=58564"},"modified":"2016-04-05T21:03:02","modified_gmt":"2016-04-05T21:03:02","slug":"global-autoimmune-diseases-drugs-market-to-grow-at-a-cagr-of-557-to-2020","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-autoimmune-diseases-drugs-market-to-grow-at-a-cagr-of-557-to-2020_58564.html","title":{"rendered":"Global Autoimmune Diseases Drugs Market to Grow at a CAGR of 5.57% to 2020"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/04\/a1455115183.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/04\/a1455115183.png\" alt=\"\" width=\"219\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Global Autoimmune Drugs Market 2016-2020&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.<\/div>\n<p style=\"text-align: justify;\">The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.<\/p>\n<p style=\"text-align: justify;\">Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.<\/p>\n<p style=\"text-align: justify;\"><strong>Complete Report Available at: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.reportsweb.com\/global-autoimmune-drugs-market-2016-2020\">http:\/\/www.reportsweb.com\/global-autoimmune-drugs-market-2016-2020<\/a><strong><br \/><\/strong><\/p>\n<p style=\"text-align: justify;\">Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases. The market is divided into Americas, APAC, and EMEA based on geography. Promising pipeline is considered as market driver whereas Loss of patent exclusivity of branded therapies come up as market challenge.<\/p>\n<p style=\"text-align: justify;\"><strong>Key questions answered in this report: <\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211; What will the market size be in 2020 and what will the growth rate be?<\/p>\n<p style=\"text-align: justify;\">&#8211; What are the key market trends?<\/p>\n<p style=\"text-align: justify;\">&#8211; What is driving this market?<\/p>\n<p style=\"text-align: justify;\">&#8211; What are the challenges to market growth?<\/p>\n<p style=\"text-align: justify;\">&#8211; Who are the Key vendors in this market space?<\/p>\n<p style=\"text-align: justify;\">&#8211; What are the market opportunities and threats faced by the key vendors?<\/p>\n<p style=\"text-align: justify;\">&#8211; What are the strengths and weaknesses of the key vendors?<\/p>\n<p style=\"text-align: justify;\"><strong><br \/>Purchase this Report at: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.reportsweb.com\/buy&amp;RW0001166686\/buy\/2500\">http:\/\/www.reportsweb.com\/buy&amp;RW0001166686\/buy\/2500<\/a><strong><br \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><br \/>Table of Content:<\/strong><\/p>\n<p style=\"text-align: justify;\">01: Executive summary<\/p>\n<p style=\"text-align: justify;\">02: Scope of the report<\/p>\n<p style=\"text-align: justify;\">03: Market research methodology<\/p>\n<p style=\"text-align: justify;\">04: Introduction<\/p>\n<p style=\"text-align: justify;\">05: Disease overview<\/p>\n<p style=\"text-align: justify;\">06: Pipeline portfolio<\/p>\n<p style=\"text-align: justify;\">07: Market landscape<\/p>\n<p style=\"text-align: justify;\">08: Market segmentation by type of disease<\/p>\n<p style=\"text-align: justify;\">09: Market segmentation by mechanism of action<\/p>\n<p style=\"text-align: justify;\">10: Market segmentation by drug class<\/p>\n<p style=\"text-align: justify;\">11: Market segmentation by type of molecule<\/p>\n<p style=\"text-align: justify;\">12: Market segmentation by ROA<\/p>\n<p style=\"text-align: justify;\">13: Market segmentation by dosage form<\/p>\n<p style=\"text-align: justify;\">14: Geographical segmentation<\/p>\n<p style=\"text-align: justify;\">15: Market drivers<\/p>\n<p style=\"text-align: justify;\">16: Impact of drivers<\/p>\n<p style=\"text-align: justify;\">17: Market challenges<\/p>\n<p style=\"text-align: justify;\">18: Impact of drivers and challenges<\/p>\n<p style=\"text-align: justify;\">19: Market trends<\/p>\n<p style=\"text-align: justify;\">20: Vendor landscape<\/p>\n<p style=\"text-align: justify;\">21: Appendix<\/p>\n<p style=\"text-align: justify;\">22: Explore Publisher<\/p>\n<p style=\"text-align: justify;\"><strong><br \/>Get Sample Report at: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.reportsweb.com\/inquiry&amp;RW0001166686\/sample\">http:\/\/www.reportsweb.com\/inquiry&amp;RW0001166686\/sample<\/a><strong><br \/><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> ReportsWeb<br \/><strong>Contact Person:<\/strong> Rajat Sahni<br \/><strong>Email:<\/strong> sales@reportsweb.com<br \/><strong>Phone:<\/strong> +1-646-491-9876<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.reportsweb.com\/global-autoimmune-drugs-market-2016-2020\" target=\"_blank\" rel=\"nofollow\">http:\/\/www.reportsweb.com\/global-autoimmune-drugs-market-2016-2020<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.reportsweb.com\/global-autoimmune-drugs-market-2016-2020\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-autoimmune-diseases-drugs-market-to-grow-at-a-cagr-of-557-to-2020\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Global Autoimmune Drugs Market 2016-2020&#8221; Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/global-autoimmune-diseases-drugs-market-to-grow-at-a-cagr-of-557-to-2020_58564.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-58564","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/58564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=58564"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/58564\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=58564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=58564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=58564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}